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 Abstract 
  Background:  Hemorrhage volume is an important predictor of outcome in patients with intra-
cerebral hemorrhage (ICH). It is not clear why in some patients ICH volume is larger than in oth-
ers. Identification of modifiable factors responsible for large-volume hemorrhage in hyperten-
sive patients may help to reduce ICH-related morbidity and mortality.  Objective:  The objective 
of this study was to identify predictors of large-volume ICH in hypertensive patients.  Methods:  
At a tertiary care center in Karachi (Pakistan), 157 hypertensive patients with ICH were prospec-
tively analyzed in 2008–2009, and hemorrhage volumes were determined using CT or MRI and 
various factors, including duration of hypertension, medical treatment, compliance, co-morbid-
ity, and hematologic and coagulation profiles. Logistic regression analysis was used to identify 
predictors of high-volume hemorrhage. A volume   1 30  mm 3   was defined as high-volume hem-
orrhage.   Results:   Of 157 patients with hypertensive ICH evaluated, 133 patients were included 
in the study, and 24 patients with brain stem, cerebellum and pure intraventricular hemorrhage 
were excluded. The mean age of the study patients was 55 years; 56 patients (70%) were male. 
High-volume hemorrhage ( 1 30 mm 3 ) was noted in 47 (35%) patients. Mortality was significant-
ly increased in patients with high-volume ICH (32 vs. 6% in patients with low-volume ICH). In 
univariate analysis, factors significantly associated with large-volume ICH were male gender
(p = 0.002), hypertension lasting   1  10 years (p = 0.03), warfarin treatment (p = 0.05), use of   1 1 
anti-hypertensive agent (p = 0.001) and poor compliance with medication (p = 0.001). In multi-
variate analysis, use of  1 1 anti-hypertensive agent and poor compliance were also predictors of 
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large-volume ICH.   Conclusion:   High-volume hemorrhage was less common (28%) in our pa-
tients with hypertension and ICH. Use of  1 1 anti-hypertensive agent and poor compliance were 
predictors of large-volume ICH.    Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Intracerebral hemorrhage (ICH) is the cause of stroke in about 30–40% of stroke patients 
in Pakistan   [1]  . The hemorrhage volume is an important predictor of outcome in ICH pa-
tients   [2]  , and it is well known that an increased hemorrhage volume in ICH patients is as-
sociated with increased functional disability and mortality. One study demonstrated that the 
predicted 30-day mortality was 93% for ICH volumes  1 60 mm 3 , 64% for those from 30 to 60 
mm  3   and 19% for those   ! 30  mm 3     [3]  . In another study, warfarin treatment in patients with 
INR   1  3.0 was associated with larger ICH volumes   [4]  . Apart from anticoagulation, it is not 
well known why some patients have large-volume and others small-volume hemorrhage. Re-
lationships between ICH volume and duration of hypertension, number and types of anti-
hypertensive medications, drug compliance and blood pressure (BP) control 3–6 months 
prior to the ICH event have not been elucidated yet.
    Identification of modifiable factors associated with large-volume hemorrhage in hyper-
tensive patients may help to reduce morbidity and mortality related to ICH. Therefore, the 
objective of this study was to identify predictors of large-volume ICH in hypertensive pa-
tients.
  M e t h o d s  
  We prospectively analyzed 157 consecutive hypertensive patients admitted for ICH in 
2008–2009 at the Aga Khan University, a tertiary care center in Karachi, Pakistan. Their ICH 
volumes were assessed using CT or MRI, and various factors, including duration of hyper-
tension, medical treatment, compliance, co-morbidity, and hematologic and coagulation 
profiles, were determined. An ICH volume   1 30  mm 3   was defined as high-volume ICH, 
which was calculated using Broderick’s method   [3, 5]  .
    Hypertension was defined as a history of hypertension, BP   1  140 (systolic) and/or   1 90 
(diastolic) mm Hg on   6  3 measurements during hospitalization or treatment with anti-hy-
pertensive drugs. Diabetes mellitus was defined as a history of diabetes mellitus and fasting 
serum glucose levels   1  110 mg/dl, or treatment with insulin or hypoglycemic drugs. Dyslip-
idemia was defined as a fasting total blood cholesterol   6  200 mg/dl and/or LDL cholesterol 
  6  100 mg/dl and/or triglycerides   6  150 mg/dl. Patients smoking   6  10 cigarettes/day for   1 10 
years were classified as smokers. Patients or immediate family members were asked about 
the use of anti-hypertensive medications, compliance to these medications and quality of BP 
control at home prior to admission. Patients were regarded as non-compliant if they did not 
take half or more of their anti-hypertensive medication during the preceding month. BP 
control was classified as poor if BP was   1  140 (systolic) and/or   1  90 (diastolic) mm Hg on 
  1  50% of home measurements despite taking anti-hypertensive medication during the 
1-month period preceding the ICH event.
  The     2   test and Student’s t test were used to compare both groups regarding baseline 
characteristics and outcome. Based on the findings in univariate analysis, a logistic regres-
sion model was built to identify predictors of high-volume ICH.
    The study protocol was approved by the local ethical review committee of the hospital.3
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  R e s u l t s  
  Of the 157 hypertensive patients with ICH analyzed, 133 patients were included in the 
study. We excluded 24 patients with brain stem, cerebellum and pure intraventricular hem-
orrhage, because the volume-outcome relationship of ICH in these brain areas could be dif-
ferent from basal-ganglia, thalamic or lobar ICH.
    Mean age of the patients was 55 years (range 19–85 years), and 56 patients (70%) were 
male. Diagnosis of hypertension was known in 119 (89%) patients, while 14 (11%) were un-
aware of their diagnosis. Duration of hypertension was   1  10 years in 56 (42%) patients. Only 
81 patients (61%) were on any anti-hypertensive medication: 50 (38%) were treated with 1 
anti-hypertensive drug while 31 (23%) were on   6  2 anti-hypertensive drugs. We were able to 
retrieve the history of compliance with anti-hypertensive medication for the 1-month period 
preceding ICH in 46 patients (35%), and 25 (19%) were poorly adherent to their medication.
    Other co-morbidities included diabetes (23; 17%), dyslipidemia (11; 8%) and cigarette 
smoking (20; 15%). Anti-platelet medication was taken by 49 (37%) patients, while 8 (6%) pa-
tients were on warfarin.
    CT scans were performed within 24 h of symptom onset in all patients. ICH were lo-
cated in the basal ganglia and thalamus in 98 (74%) patients, and lobar ICH was noted in 35 
(26%) patients. The mean ICH volume was 26 mm  3  (range 8–96 mm  3 ), ranging from 23 mm  3  
in basal ganglia/thalamus to 29 mm  3   in lobar areas. This difference was not statistically sig-
nificant (p = 0.09). ICH volume was   ! 30  mm 3   in 86 (65%) patients, while 47 (35%) patients 
had high-volume ICH (  1   30 mm  3  ). Mortality was significantly higher (32%) in patients with 
high-volume ICH compared to patients with low-volume ICH (6%).
Table 1.   Predictors of high-volume (>30 ml) hemorrhage in univariate analysis
Patient characteristics P  atients, n (%)   Odds ratio 
(95% confidence interval)
p
value
ICH ≤30 ml ICH >30 ml  
Patients evaluated 86 (65) 47 (35)
Age <60 years 50 (58) 34 (72) 0.53 (0.24–1.14) 0.10
Male gender 48 (55.8) 38 (80.9) 3.34 (1.44–7.75) 0.005
Duration of hypertension
>10 years 43 (50) 13 (27.7) 0.39 (0.16–0.92) 0.07
Anti-hypertensive treatment 
1 anti-hypertensive agent 34 (40.5) 16 (35.6) 0.39 (0.17–0.90) 0.069
≥2 anti-hypertensive agents 7 (8) 24 (51) 14.92 (3.46–45.57) <0.001
Poor compliance  8 (9.3) 17 (36.2) 10.09 (2.57–39.60) 0.001
BP control
Regular home monitoring 74 (86) 35 (74.5) 0.47 (0.19–1.15) 0.10
Poor during the last month 64 (74.4) 40 (85.1) 0.50 (0.19–1.30) 0.15
By a physician during the last 3 months 10 (11.6) 8 (17) 1.55 (0.57–4.26) 0.38
Diabetes mellitus 16 (19) 7 (15) 0.73 (0.35–1.96) 0.09
Duration >10 years 5 (6) 2 (4) 0.51 (0.22–0.97) 0.098
Blood glucose >150 mg/dl on admission 14 (16) 5 (10) 0.97 (0.35–2.13) 0.63
Dyslipidemia 8 (9) 3 (6) 0.55 (0.11–1.19) 0.11
Statin treatment at home 3 (4) 1 (2) 0.21 (0.09–0.87) 0.22
Smoking status 13 (15) 7 (15) 0.47 (0.11–1.25) 0.9
Medication
Anti-platelets 35 (41) 14 (30) 1.02 (0.54–3.15) 0.06
Warfarin 2 (2) 6 (13) 7.55 (1.24–19.55) 0.05
Platelet count <50,000 on admission 8 (9) 3 (6) 0.83 (0.31–2.01) 0.09
INR >3.0 on admission 1 5 (10) 10.50 (2.25–31.45) 0.044
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    Male gender (p = 0.005), use of warfarin (p = 0.05), INR   1  3.0 on admission (p = 0.04), 
use of   1  1 anti-hypertensive agent (p = 0.001) and poor compliance with medication (p = 
0.001) were associated with large-volume ICH in univariate analysis (  table 1  ).
    In multivariate analysis, predictors of large-volume ICH were use of   1 1  anti-hyperten-
sive agent and poor compliance (  table 2  ).
  Discussion 
  These findings indicate that more than one third of patients in this tertiary hospital re-
ferral setting had high-volume ICH, and use of   6  2 anti-hypertensive agents and poor com-
pliance with anti-hypertensive medication were the strongest predictors of high-volume 
hemorrhage. Patients treated with   6  2 anti-hypertensive drugs most likely represent aggres-
sive forms of hypertension, and non-compliance is probably associated with sustained 
  uncontrolled BP. These findings may also be a sign of more careful management of hyper-
tension (despite lesser compliance) by doctors. They may also suggest that during acute 
bleeding, the presence of more vasoplegic medication triggers a longer and more intense 
hemorrhage, or that a lower BP in the acute phase is associated with lower intracranial pres-
sure (compared with patients with higher BP), resulting in prolonged and larger bleeding. 
Poor compliance with warfarin, in addition to anti-hypertensive medication, may be associ-
ated with an increased risk of hemorrhage.
    Morbidity and mortality related to high-volume ICH could be reduced by interventions 
aiming to lower hemorrhage volume among these patients. It is well known from non-ran-
domized subgroup evaluation in randomized trials (e.g. PROGRESS) and extrapolation from 
observation studies that aggressive BP control is associated with a lower incidence of ICH, 
suggesting that aggressive BP control may lead to smaller-volume hemorrhage with lower 
mortality. Our study confirms previous reports of a correlation between warfarin treatment 
and high INR and large-volume ICH [6].
    A limitation of this study is its small number of study patients and limited available in-
formation regarding some aspects of BP control and medication compliance. Larger multi-
center studies are required to confirm our findings.
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Table 2.   Predictors of high-volume (>30 ml) hemorrhage in multivariate analysis
Patient characteristics Adjusted odds ratio
(95% confidence interval)
p value
Male gender 2.85 (0.99–8.23) 0.06
Treatment with ≥2 anti-hypertensive agents 19.55 (3.01–54.43) 0.002
Poor compliance with anti-hypertensive medication 17.85 (3.17–43.86) 0.005
Warfarin use 9.67 (2.53–37.87) 0.02
INR >3.0 on admission 12.59 (2.94–44.89) 0.015
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